Back to Search
Start Over
Metformin and body weight
- Source :
- International journal of obesity, Vol. 32, No 1 (2008) pp. 61-72
- Publication Year :
- 2008
-
Abstract
- Most patients with type 2 diabetes are overweight or obese, overweight or obesity increases the risk of developing type 2 diabetes and obesity per se is strongly associated with multiple cardiometabolic risk factors. However, many antidiabetic treatments increase body weight. The oral antidiabetic agent, metformin, has been evaluated in hundreds of clinical studies in diverse patient populations during approximately five decades of clinical use. This review summarizes the effects of metformin on body weight, with special reference to studies of longer duration (>/=6 months) as both diabetes and obesity are long-term conditions. Approximately half of studies in drug-naive type 2 diabetic patients demonstrated significant weight loss with metformin compared with baseline or comparator drugs, although pooled analyses have suggested no significant effect versus placebo. Similarly, metformin has been shown to induce weight loss in obese nondiabetic populations, although studies of long duration in this population are scarce. Metformin does appear to mitigate the adverse effects of insulin on body weight. The weight-neutral or weight-sparing effects of metformin constitute a therapeutic advantage in diabetes management where other first-line oral antidiabetic treatments often promote clinically significant weight gain.
- Subjects :
- Adult
Male
medicine.medical_specialty
Diabetes Mellitus Type 2/complications/drug therapy
Adolescent
Endocrinology, Diabetes and Metabolism
Medicine (miscellaneous)
Type 2 diabetes
Overweight
Hypoglycemic Agents/adverse effects
Weight loss
Diabetes management
Internal medicine
Diabetes mellitus
medicine
Hypoglycemic Agents
Humans
Obesity
Body Weight/drug effects
Longitudinal Studies
Child
Metformin/adverse effects
ddc:613
Nutrition and Dietetics
business.industry
Body Weight
Middle Aged
medicine.disease
Metformin
Endocrinology
Diabetes Mellitus, Type 2
Obesity/chemically induced
Female
medicine.symptom
business
Weight gain
medicine.drug
Subjects
Details
- Language :
- English
- ISSN :
- 14765497
- Database :
- OpenAIRE
- Journal :
- International journal of obesity, Vol. 32, No 1 (2008) pp. 61-72
- Accession number :
- edsair.doi.dedup.....3a42c76f5d9923e4ac75f67e9c65435c